Endothelial dysfunction in preeclampsia. Part I: Primary prevention. Therapeutic perspectives.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Perinatal Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1515/JPME.1996.24.2.99PMID 8773938
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatocellular lipofuscin in pre-eclampsia.

  2010cited by this paper
• 7b The pharmacological prevention of pre-eclampsia

  1995cited by this paper
• LIPID PEROXIDATION IN PREGNANCY

  1994cited by this paper
• Which plasma factors bring about disturbance of endothelial function in pre-eclampsia?

  1994cited by this paper
• Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model.

  1994cited by this paper
• Pre-eclampsia and serum antibodies to oxidised low-density lipoprotein.

  1994cited by this paper
• Inhibition of inducible nitric oxide synthase in macrophages by oxidized low-density lipoproteins.

  1994cited by this paper
• Expression of the nonclassic histocompatibility antigen HLA-G by preeclamptic placenta.

  1994cited by this paper
• Carvedilol, a new antihypertensive agent, prevents lipid peroxidation and oxidative injury to endothelial cells.

  1993cited by this paper
• Vitamin E, LDL, and endothelium. Brief oral vitamin supplementation prevents oxidized LDL-mediated vascular injury in vitro.

  1993cited by this paper
• Findings on lipid peroxidation and antioxidant function in hypertensive complications of pregnancy

  1993cited by this paper
• Transferable lipids in oxidized low-density lipoprotein stimulate plasminogen activator inhibitor-1 and inhibit tissue-type plasminogen activator release from endothelial cells.

  1993cited by this paper
• Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study.

  1993cited by this paper
• Pre-eclampsia is associated with an increase in trophoblast glycogen content and glycogen synthase activity, similar to that found in hydatidiform moles.

  1993cited by this paper
• Deficient glutathione peroxidase activity in preeclampsia is associated with increased placental production of thromboxane and lipid peroxides.

  1993cited by this paper
• Towards the physiological function of uric acid.

  1993cited by this paper
• A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta.

  1993cited by this paper
• Paternity patterns and risk of preeclampsia in the last pregnancy in multiparae.

  1993cited by this paper
• Vitamin E consumption and the risk of coronary disease in women.

  1993cited by this paper
• The Superoxide Generation of Neutrophils in Normal and Preeclamptic Pregnancies

  1993cited by this paper
• Vitamin E consumption and the risk of coronary heart disease in men.

  1993cited by this paper
• Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event.

  1993cited by this paper
• Pre‐eclampsia and cytokine induced oxidative stress

  1993cited by this paper
• Antioxidants in adipose tissue and risk of myocardial infarction: the EURAMIC Study.

  1993cited by this paper
• Prospects for the prevention of free radical disease, regarding cancer and cardiovascular disease.

  1993cited by this paper
• Probucol and other antioxidants prevent the inhibition of endothelium-dependent relaxation by low density lipoproteins.

  1993cited by this paper
• Ketanserin, A 5-Ht 2 Serotonergic Receptor Antagonist, Could Be Useful in the Hellp Syndrome

  1993cited by this paper
• Genetics of Pre-Eclampsia

  1993cited by this paper
• Plasma Peroxyl Radical-Trapping Capacity in Severe Preeclampsia is Strongly Related to Uric Acid

  1992cited by this paper
• N-acetylcysteine and glutathione as inhibitors of tumor necrosis factor production.

  1992cited by this paper
• Increased lipolytic activity and high ratio of free fatty acids to albumin in sera from women with preeclampsia leads to triglyceride accumulation in cultured endothelial cells.

  1992cited by this paper
• Galactose alpha 1-3 galactose and anti-alpha galactose antibody in normal and pathological pregnancies.

  1992cited by this paper
• Sera antioxidant activity in uncomplicated and preeclamptic pregnancies

  1992cited by this paper
• Pathogenesis of preeclampsia: a hypothesis.

  1992cited by this paper
• Trophoblast deportation in pre‐eclamptic pregnancy

  1991cited by this paper
• Reactive oxygen species in living systems: source, biochemistry, and role in human disease.

  1991cited by this paper
• Endomyocardial ultrastructural findings in preeclampsia.

  1991cited by this paper
• Activation of human blood monocytes by oxidized polyunsaturated fatty acids: a possible mechanism for the generation of lipid peroxides in the circulation.

  1991cited by this paper
• Myocardial reperfusion injury: mechanisms and management--a review.

  1991cited by this paper
• Clinical Pharmacokinetics of N-Acetylcysteine

  1991cited by this paper
• Oxidation of membrane cholesterol alters active and passive transsarcolemmal calcium movement.

  1991cited by this paper
• Oxidant-antioxidant balance: some observations from studies of ischemia-reperfusion in isolated perfused rat hearts.

  1991cited by this paper
• Mechanisms of endothelial cell killing by H2O2 or products of activated neutrophils.

  1991cited by this paper
• Endothelin, elastase, and endothelial dysfunction in pre-eclampsia.

  1991cited by this paper
• Maternal levels of prostacyclin, thromboxane, vitamin E, and lipid peroxides throughout normal pregnancy.

  1991cited by this paper
• Immunologic Aspects of Preeclampsia

  1991cited by this paper
• Transplacental transport of N-acetylcysteine in an ovine model.

  1991cited by this paper
• N-acetylcysteine in experimental and clinical acute lung injury.

  1991cited by this paper
• Oxidative stress: from basic research to clinical application.

  1991cited by this paper
• Immunocytochemical localization of neutrophil elastase in term placenta decidua and myometrium in pregnancy‐induced hypertension

  1991cited by this paper
• Growth factor activity in the blood of women in whom preeclampsia develops is elevated from early pregnancy.

  1990cited by this paper
• Genetic and familial predisposition to eclampsia and pre‐eclampsia in a defined population

  1990cited by this paper
• New developments in pre-eclampsia

  1990cited by this paper
• Erythrocyte glutathione peroxidase activity in hypertensive complications of pregnancy.

  1990cited by this paper
• Increased plasma levels of ED1+ cellular fibronectin precede the clinical signs of preeclampsia.

  1990cited by this paper
• Micronutrients and drug response: vitamin A and vitamin E in the fetus and in the newborn.

  1990cited by this paper
• Protective effect of vitamin E on fetal distress induced by ischemia of the uteroplacental system in pregnant rats.

  1990cited by this paper
• Ultrastructural aspects of preeclampsia. II. Mitochondrial changes.

  1990cited by this paper
• Anti-vascular endothelial cell antibodies in severe preeclampsia.

  1990cited by this paper
• The fetal allograft

  1990cited by this paper
• The endothelium. Target and promoter of hypertension?

  1990cited by this paper
• Regulatory functions of the vascular endothelium.

  1990cited by this paper
• Role of free radicals and catalytic metal ions in human disease: an overview.

  1990cited by this paper
• Endothelium and Control of Vascular Function State of the Art Lecture

  1989cited by this paper
• Lipid peroxidation in pregnancy: New perspectives on preeclampsia

  1989cited by this paper
• Predictive value of increased plasma levels of fibronectin in gestational hypertension

  1989cited by this paper
• Neutrophil activation in pregnancy‐induced hypertension

  1989cited by this paper
• Ultrastructural aspects of preeclampsia. I. Placental bed and uterine boundary vessels.

  1989cited by this paper
• In vivo administration of allopurinol affects ovulation and early embryonic development in rabbits.

  1989cited by this paper
• Mediator‐induced activation of xanthine oxidase in endothelial cells

  1989cited by this paper
• Lipid peroxidation and altered vascular function in vitamin E-deficient rats.

  1989cited by this paper
• Pre‐Eclampsia‐A Mitochondrial Disease?

  1989cited by this paper
• Maternal and fetal vitamin E concentrations and selenium-vitamin E interrelationships in dairy cattle.

  1989cited by this paper
• Preeclampsia: an endothelial cell disorder.

  1989cited by this paper
• Oxygen radicals in CNS damage.

  1989cited by this paper
• Myocardial glutathione depletion impairs recovery after short periods of ischemia.

  1989cited by this paper
• Deleterious Effects of Oxygen Radicals in Ischemia/Reperfusion Resolved and Unresolved Issues

  1989cited by this paper
• Endothelium-dependent vascular responses. Mediators and mechanisms.

  1989cited by this paper
• Upper limit of vitamin E in infant formulas.

  1989cited by this paper
• Protection of rat myocardial phospholipid against peroxidative injury through superoxide-(xanthine oxidase)-dependent, iron-promoted Fenton chemistry by the male contraceptive gossypol.

  1988cited by this paper
• Trophoblast membrane infusion for unexplained recurrent miscarriage

  1988cited by this paper
• Placental-type plasminogen activator inhibitor in preeclampsia.

  1988cited by this paper
• ARACHIDONIC ACID DERIVATIVES IN THE PATHOPHYSIOLOGY OF PREGNANCY-INDUCED HYPERTENSION

  1988cited by this paper
• Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells.

  1988cited by this paper
• Effects of N-acetylcysteine on fetal development and on phenytoin teratogenicity in mice.

  1988cited by this paper
• The role of glutathione status in the protection against ischaemic and reperfusion damage: effects of N-acetyl cysteine.

  1988cited by this paper
• Pharmacology of vitamin E in the newborn.

  1987cited by this paper
• Lipid peroxidation and vitamin E levels during pregnancy in rats.

  1987cited by this paper
• Predictive value of fibronectin levels in normotensive gravid women destined to become preeclamptic.

  1986cited by this paper
• Oxygen-derived free radicals in postischemic tissue injury.

  1985cited by this paper
• Preeclampsia: an imbalance in placental prostacyclin and thromboxane production.

  1985cited by this paper
• Selenium enhances prostacyclin production by cultured endothelial cells: possible explanation for increased bleeding times in volunteers taking selenium as a dietary supplement.

  1984cited by this paper
• Unbalanced plasma control of TxA2 and PGI2 synthesis in vitamin E-deficient rats.

  1983cited by this paper
• Inhibition of cyclo-oxygenase and lipoxygenase.

  1983cited by this paper
• Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study.

  1982cited by this paper
• Free-Radical Oxidation (Peroxidation) Products in Plasma in Normal and Abnormal Pregnancy

  1981cited by this paper
• Lipid peroxide levels and lipid content of serum lipoprotein fractions of pregnant subjects with or without pre-eclampsia

  1981cited by this paper
• An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

  1976cited by this paper
• Transplacental carcinogenesis by stilbestrol.

  1971cited by this paper
• Tumor angiogenesis: therapeutic implications.

  1971cited by this paper

• Comparison of Diagnostic Values of Maternal Arginine Concentration for Different Pregnancy Complications: A Systematic Review and Meta-Analysis

  2022cites this paper
• There is a Strong Association between Early Preeclampsia and Congenital Heart Defects: A Large Population-Based, Retrospective Study

  2020cites this paper
• Podocalyxin levels in preeclampsia and relationship with severity of disease

  2020cites this paper
• Maternal circulating concentrations of soluble Fas and Elabela in early- and late-onset preeclampsia

  2020cites this paper
• ELABELA plasma concentrations are increased in women with late-onset preeclampsia

  2018cites this paper
• Serum caveolin-1 levels in patients with preeclampsia

  2018cites this paper
• The prediction of late-onset preeclampsia: Results from a longitudinal proteomics study

  2017cites this paper
• Endothelial Cell Dysfunction

  2015cites this paper
• The anti-aging factor α-klotho during human pregnancy and its expression in pregnancies complicated by small-for-gestational-age neonates and/or preeclampsia

  2014cites this paper
• Maternal plasma soluble TRAIL is decreased in preeclampsia

  2014cites this paper
• STUDY OF LIPID PROFILE TRENDS IN WOMEN OF PREGNANCY INDUCED HYPERTENSION CASES IN A RURAL SETUP

  2013cites this paper
• Significance of platelet endothelial cell adhesion molecule-1 (PECAM-1) and intercellular adhesion molecule-1 (ICAM-1) expressions in preeclamptic placentae

  2012cites this paper
• Expression levels of cyclooxygenase-2, tumor necrosis factor-α and inducible NO synthase in placental tissue of normal and preeclamptic pregnancies

  2012cites this paper
• The effects of fumonisin B¹ in preeclampsia.

  2012cites this paper
• Microangiopatía en la preeclampsia: utilidad del frotis de sangre periférica

  2012cites this paper
• Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia

  2011cites this paper
• Efecto de la terapia temprana con L-arginina en el crecimiento intrauterino restringido en la preclampsia. Estudio aleatorizado en mujeres latinoamericanas

  2009cites this paper
• Endothelial Cell Dysfunction and Oxidative Stress

  2009cites this paper
• Comparison of antioxidant enzyme activity in the internal spermatic vein and brachial veins of patients with infertile varicocele

  2008cites this paper
• Antithrombin plasma levels decrease is associated with preeclampsia worsening

  2007cites this paper
• Effects of oral L-arginine on the foetal condition and neonatal outcome in preeclampsia: a preliminary report.

  2006cites this paper
• Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia.

  2006cites this paper
• Microangiopatía trombótica y hemólisis intravascular en hipertensión por embarazo. La mentira del síndrome de HELLP

  2006cites this paper
• The microangiopathy of pregnancy

  2005cites this paper
• Die Bedeutung des Transkriptionsfaktors NF-KB und entzündlicher Reaktionen in der Pathogenese arteriosklerotischer und hypertensiver Gefäßschäden

  2004influential citation
• [New insight in physiopathology of preeclampsia and intra-uterine growth retardation: role of inflammation].

  2004cites this paper
• Avancées dans la physiopathologie de la pré-éclampsie : place de la réponse inflammatoire

  2004cites this paper
• Expression of Vascular Endothelial Growth Factor in Peripheral Blood Cells of Preeclamptic Women

  2003cites this paper
• Triglyceride-rich lipoproteins are associated with hypertension in preeclampsia.

  2003cites this paper
• Hypertensieve aandoeningen in de zwangerschap: pre-eclampsie en HELLP-syndroom.

  2002cites this paper
• Preeclampsia - maternal risk factors and fetal growth

  2002cites this paper
• Preeclampsia and other circulatory diseases during pregnancy : etiological aspects and impact on female offspring

  2001cites this paper
• The physiological role of estriol during human fetal development is to act as antioxidant at lipophilic milieus of the central nervous system.

  2001cites this paper
• Risk factors for renal abnormalities in a nondiabetic population

  2001cites this paper
• Possible Beneficial Effect of Exercise, by Reducing Oxidative Stress, on the Incidence of Preeclampsia

  2001cites this paper
• Endothelial function in myometrial resistance arteries of normal pregnant women perfused with syncytiotrophoblast microvillous membranes

  2001cites this paper
• Pre-eclampsia: clinical associations and pathological changes.

  2001cites this paper
• Anästhesiologische und intensivmedizinische Aspekte bei Patientinnen mit Gestose

  2000cites this paper
• Sublingual Isosorbide Dinitrate in the Acute Control of Hypertension in Patients with Severe Preeclampsia

  2000cites this paper
• The expression and activity of monoamine oxidase A, but not of the serotonin transporter, is decreased in human placenta from pre-eclamptic pregnancies.

  2000cites this paper
• Vascular function in preeclampsia.

  2000cites this paper
• Vascular endothelial growth factor, its receptors, and the Tie receptor in normal and complicated pregnancy

  2000cites this paper
• What causes pre-eclampsia?

  1999cites this paper
• Endothelial cell lesion in preeclampsia. Morphofunctional study using umbilical endothelial cells.

  1999cites this paper
• Ketanserin versus dihydralazine in the management of severe early-onset preeclampsia: maternal outcome.

  1999cites this paper
• PREECLAMPSIA: Clinical Characteristics and Pathogenesis

  1999cites this paper
• Endothelial Cell Lesion in Preeclampsia

  1999cites this paper
• Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre‐eclampsia

  1999cites this paper
• Altered Lipid Metabolism in Preeclampsia and HELLP Syndrome: Links to Enhanced Platelet Reactivity and Fetal Growth

  1999cites this paper
• Circulating Factors as Markers and Mediators of Endothelial Cell Dysfunction in Preeclampsia

  1998cites this paper
• Mediation by 5-HT2 receptors of 5-hydroxytryptamine-induced contractions of human placental vein.

  1998cites this paper
• Vasoactive mediators in pregnancy-induced hypertensive disorders: a longitudinal study.

  1998cites this paper
• Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction.

  1998cites this paper
• Transient Cortical Blindness in Preeclampsia With Indication of Generalized Vascular Endothelial Damage

  1998cites this paper
• Seasonal change in the incidence of preeclampsia in Zimbabwe

  1998cites this paper
• Immune maladaptation in the etiology of preeclampsia: a review of corroborative epidemiologic studies.

  1998cites this paper
• Pathogenesis of preeclampsia: a comprehensive model.

  1998cites this paper
• The haemodynamic effects of ketanserin versus dihydralazine in severe early‐onset hypertension in pregnancy

  1998cites this paper
• Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study.

  1998cites this paper
• Cyclooxygenase-1 and -2 in human placenta and placental bed after normal and pre-eclamptic pregnancies.

  1997cites this paper
• Endothelial dysfunction in preeclampsia. Part II: Reducing the adverse consequences of endothelial cell dysfunction in preeclampsia; therapeutic perspectives

  1996cites this paper